- Nachrichtendetail
-
27.02.2024 13:04:30 - dpa-AFX: *LIGAND PHARMA Q4 CORE ADJ. NET INCOME RISES TO $18.6 MLN OR $1.05/SHR FROM $13.0 MLN OR $0.75/SHR LAST YEAR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 90,735 | 09.07.24 21:22:53 | +3,855 | +4,44% | 90,630 | 90,920 | 87,780 | 86,880 |
